Multivitamin capable of beneficial gene regulation through microRNA (miRNA)
US10426756B2 · kind B2 · utility
0Cited by
1References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 4, 2017 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | Aug 4, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes compositions and methods for modifying the expression of microRNAs comprising: one or more plant secondary metabolites capable of beneficially regulating different genes in the human genome by modifying the expression of one or more microRNAs, wherein the one or more plant secondary metabolites are selected and provided in an amount selected to target the modification of one or more specific microRNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.